The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues
Abstract
Controlled clinical trials are recognized as the best source of data on the efficacy of health care interventions and technologies. Because economic evaluation is dependent on the quality of the underlying medical evidence, clinical trials have increasingly been viewed as a natural vehicle for economic analysis. However, the closer integration of economic and clinical research raises many methodological issues. This paper discusses these issues in trial design, collection of resource use data, collection of outcome data, and interpretation and extrapolation of results. Some guidelines are suggested for economic analysts wishing to undertake evaluations alongside clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Meta-Analysis in Clinical Research
L'ABBÉ, K. A., DETSKY, A. S., & O'ROURKE, K. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-224 · Cited by 1,267 · cited 1×
“More recently there has been a trend toward "meta-analyses" of a series of trial results (4) and the combination of trial data with data gathered by observation or survey (24).”
BackgroundUtility approach to measuring health-related quality of life
Torrance, G. W. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90019-1 · Cited by 1,072
The Distinction Between Cost and Charges
FINKLER, S. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-1-102 · Cited by 1,052
Utilities and Quality-Adjusted Life Years
Torrance, G. W., & Feeny, D. (1989) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300008461 · Cited by 818
Economics of coronary artery bypass grafting.
Williams, A. (1985) · BMJ · doi:10.1136/bmj.291.6491.326 · Cited by 711
Quality of life assessments in clinical trials
(1991) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(91)90459-p · Cited by 692
Bergner, M., Bobbitt, R. A., Kressel, S., Pollard, W. E., Gilson, B. S., & Morris, J. R. (1976) · International Journal of Health Services · doi:10.2190/rhe0-ggh4-410w-la17 · Cited by 643
Application of Multi-Attribute Utility Theory to Measure Social Preferences for Health States
Torrance, G. W., Boyle, M. H., & Horwood, S. P. (1982) · Operations Research · doi:10.1287/opre.30.6.1043 · Cited by 520
Quality-adjusted life years, utility theory, and healthy-years equivalents
Mehrez, A., & Gafni, A. (1989) · Medical Decision Making · doi:10.1177/0272989x8900900209 · Cited by 469 · cited 1×
“It is therefore clear that there is a cost-quality-mortality trade-off between the two therapies; it is the kind of trade-off that economists would argue is best handled through the calculation of QALYs or healthy year equivalents (25) and relating the QALYs gained to cost.”
BackgroundIncorporating Utility-Based Quality-of-Life Assessment Measures in Clinical Trials: Two Examples
Feeny, D. H., & Torrance, G. W. (1989) · Medical Care · doi:10.1097/00005650-198903001-00016 · Cited by 166
The science of quality of life
Katz, S. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90001-4 · Cited by 158
Economic analysis and clinical trials
Drummond, M., & Stoddart, G. L. (1984) · Controlled Clinical Trials · doi:10.1016/0197-2456(84)90118-1 · Cited by 132
Self-citationEconomic appraisal of health technology in the european community
Ghelijns, A. T. (1988) · Health Policy · doi:10.1016/0168-8510(88)90039-5 · Cited by 121
Costt-Effectiveness of Antepartum Prevention of Rh Immunization
Torrance, G. W., & Zipursky, A. (1984) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30920-5 · Cited by 95
Economic Evaluation of A Support Program for Caregivers of Demented Elderly
Drummond, M., Mohide, E. A., Tew, M., Streiner, D. L., Pringle, D. M., & Gilbert, J. R. (1991) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300005109 · Cited by 93
Self-citationEconomic Evaluation of Pharmaceuticals: A European Perspective
Drummond, M., Rutten, F., Brenna, A., Pinto, C. G., Horisberger, B., Jönsson, B., Pen, C. L., Rovira, J., von der Schulenburg, M. G., Sintonen, H., et al. (1993) · PharmacoEconomics · doi:10.2165/00019053-199304030-00003 · Cited by 86
Self-citationThe cost effectiveness of auranofin: results of a randomized clinical trial.
Ms, T., Jl, R., Hutchings, H. C., Paterson, M. E. L., & Harris, E. D. (1988) · PubMed · Cited by 86
The QALY toolkitPreprint
Gudex, C. M., & Kind, P. (1988) · RePEc: Research Papers in Economics · Cited by 78
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-11-901_1 · Cited by 71
Cited by
A study of the quality of life and cost-utility of renal transplantation
Laupacis, A., Keown, P., Pus, N., Krueger, H., Ferguson, B., Wong, C., & Muirhead, N. (1996) · Kidney International · doi:10.1038/ki.1996.307 · Cited by 1,167
Koopman, M. M. W., Prandoni, P., Piovella, F., Ockelford, P. A., Brandjes, D. P. M., van der Meer, J., Gallus, A. S., Simonneau, G., Chesterman, C. H., Prins, M. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341102 · Cited by 1,111
The Treatment of Acute Low Back Pain — Bed Rest, Exercises, or Ordinary Activity?
Malmivaara, A., Häkkinen, U., Aro, T., Heinrichs, M.-L., Koskenniemi, L., Kuosma, E., Lappi, S., Paloheimo, R., Servo, C., Vaaranen, V., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502093320602 · Cited by 615
Development of WHO guidelines on generalized cost-effectiveness analysis
Murray, C. J. L., Evans, D. B., Acharya, A., & Baltussen, R. M. P. M. (2000) · Health Economics · doi:10.1002/(sici)1099-1050(200004)9:3<235::aid-hec502>3.0.co;2-o · Cited by 577
Multimorbidity in chronic disease: impact on health care resources and costs
McPhail, S. (2016) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s97248 · Cited by 549
Metadata
- Authors
- Drummond, M. F., & Davies, L.
- Venue
- International Journal of Technology Assessment in Health Care
- Publisher
- Cambridge University Press (CUP)
- Published
- 1991
- Volume
- 7
- Issue
- 4
- Pages
- 561-573
- ISSN
- 0266-4623 (ISSN-L)
- 1471-6348
- OpenAlex
- W2101499551
- Cited by
- 337
- References
- 21
- FWCI
- 55.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.